Stella Chai

1.2k total citations
20 papers, 963 citations indexed

About

Stella Chai is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Stella Chai has authored 20 papers receiving a total of 963 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 8 papers in Oncology and 6 papers in Cancer Research. Recurrent topics in Stella Chai's work include MicroRNA in disease regulation (5 papers), Phytochemistry and Bioactive Compounds (4 papers) and Drug Transport and Resistance Mechanisms (4 papers). Stella Chai is often cited by papers focused on MicroRNA in disease regulation (5 papers), Phytochemistry and Bioactive Compounds (4 papers) and Drug Transport and Resistance Mechanisms (4 papers). Stella Chai collaborates with scholars based in Hong Kong, China and Germany. Stella Chai's co-authors include Stephanie Ma, Terence K. Lee, Man Tong, Kenneth K.W. To, Eunice Y. Lau, Ge Lin, Xin‐Yuan Guan, Jessica Lo, Irene Oi‐Lin Ng and Suk Ying Tsang and has published in prestigious journals such as Blood, Hepatology and Cancer Research.

In The Last Decade

Stella Chai

19 papers receiving 953 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stella Chai Hong Kong 15 611 367 338 143 98 20 963
Angélique Gougèlet France 15 602 1.0× 184 0.5× 348 1.0× 116 0.8× 107 1.1× 23 976
Dongxian Guan China 14 503 0.8× 255 0.7× 250 0.7× 109 0.8× 154 1.6× 17 891
Mi Kwon Son South Korea 18 418 0.7× 302 0.8× 132 0.4× 57 0.4× 65 0.7× 41 830
Dali Zhao China 12 431 0.7× 143 0.4× 293 0.9× 157 1.1× 75 0.8× 18 762
Fazong Wu China 17 507 0.8× 241 0.7× 333 1.0× 207 1.4× 189 1.9× 38 1.0k
Xiao Zhi China 14 588 1.0× 216 0.6× 275 0.8× 41 0.3× 46 0.5× 16 796
Zhouyu Ning China 19 500 0.8× 364 1.0× 357 1.1× 56 0.4× 87 0.9× 40 911
Yeonhwa Song South Korea 16 343 0.6× 297 0.8× 184 0.5× 136 1.0× 56 0.6× 25 699
Haihua Qian China 12 288 0.5× 378 1.0× 248 0.7× 173 1.2× 40 0.4× 26 738
Xiaojun Yang China 13 539 0.9× 403 1.1× 406 1.2× 34 0.2× 60 0.6× 28 944

Countries citing papers authored by Stella Chai

Since Specialization
Citations

This map shows the geographic impact of Stella Chai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stella Chai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stella Chai more than expected).

Fields of papers citing papers by Stella Chai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stella Chai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stella Chai. The network helps show where Stella Chai may publish in the future.

Co-authorship network of co-authors of Stella Chai

This figure shows the co-authorship network connecting the top 25 collaborators of Stella Chai. A scholar is included among the top collaborators of Stella Chai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stella Chai. Stella Chai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Wu, Xu, Chun Yin, Jiang Ma, et al.. (2021). Polyoxypregnanes as safe, potent, and specific ABCB1-inhibitory pro-drugs to overcome multidrug resistance in cancer chemotherapy in vitro and in vivo. Acta Pharmaceutica Sinica B. 11(7). 1885–1902. 20 indexed citations
3.
Tong, Man, Noélia Che, Lei Zhou, et al.. (2018). Efficacy of annexin A3 blockade in sensitizing hepatocellular carcinoma to sorafenib and regorafenib. Journal of Hepatology. 69(4). 826–839. 99 indexed citations
4.
Chan, Lok-Hei, Stella Chai, Man Tong, et al.. (2017). TP53INP1 Downregulation Activates a p73-Dependent DUSP10/ERK Signaling Pathway to Promote Metastasis of Hepatocellular Carcinoma. Cancer Research. 77(17). 4602–4612. 42 indexed citations
5.
To, Kenneth K.W., Xu Wu, Chun Yin, et al.. (2017). Reversal of multidrug resistance by Marsdenia tenacissima and its main active ingredients polyoxypregnanes. Journal of Ethnopharmacology. 203. 110–119. 42 indexed citations
6.
Chan, Lok-Hei, Stella Chai, Man Tong, et al.. (2017). Abstract 4842: TP53INP1 negatively regulates ERK1/2 via p73-dependent DUSP10 expression to promote metastasis in hepatocellular carcinoma. Cancer Research. 77(13_Supplement). 4842–4842. 1 indexed citations
7.
Chai, Stella, Man Tong, Eunice Y. Lau, et al.. (2017). Abstract 2895: Octamer-4/microRNA-1246 signaling axis drives Wnt/β-catenin activation in liver cancer stem cells. Cancer Research. 77(13_Supplement). 2895–2895. 2 indexed citations
8.
Yao, Sheng, Kenneth K.W. To, Liang Ma, et al.. (2016). Polyoxypregnane steroids with an open-chain sugar moiety from Marsdenia tenacissima and their chemoresistance reversal activity. Phytochemistry. 126. 47–58. 17 indexed citations
9.
Lau, Eunice Y., Jessica Lo, Bowie Y. Cheng, et al.. (2016). Cancer-Associated Fibroblasts Regulate Tumor-Initiating Cell Plasticity in Hepatocellular Carcinoma through c-Met/FRA1/HEY1 Signaling. Cell Reports. 15(6). 1175–1189. 269 indexed citations
10.
Chai, Stella, Man Tong, Xin‐Yuan Guan, et al.. (2016). C-terminal truncated hepatitis B virus X protein promotes hepatocellular carcinogenesis through induction of cancer and stem cell-like properties. Oncotarget. 7(17). 24005–24017. 49 indexed citations
11.
Tong, Man, Jinna Chen, Stella Chai, et al.. (2016). Neuropilin‐2 promotes tumourigenicity and metastasis in oesophageal squamous cell carcinoma through ERK–MAPK–ETV4–MMP–E‐cadherin deregulation. The Journal of Pathology. 239(3). 309–319. 44 indexed citations
12.
Chai, Stella, Kai‐Yu Ng, Man Tong, et al.. (2016). Octamer 4/microRNA‐1246 signaling axis drives Wnt/β‐catenin activation in liver cancer stem cells. Hepatology. 64(6). 2062–2076. 162 indexed citations
13.
Chai, Stella, et al.. (2015). Abstract 2874: Regulatory role of miRNA-1246 and Wnt/β-catenin pathway interaction in CD133+ liver cancer stem cells-driven hepatocellular carcinoma. Cancer Research. 75(15_Supplement). 2874–2874. 1 indexed citations
14.
Chai, Stella, et al.. (2015). Abstract 2223: C-terminal truncated hepatitis B virus X protein promotes hepatocarcinogenesis through enhanced stemness and resistance to therapy. Cancer Research. 75(15_Supplement). 2223–2223. 1 indexed citations
15.
Yao, Sheng, Kenneth K.W. To, Yazhou Wang, et al.. (2014). Polyoxypregnane Steroids from the Stems of Marsdenia tenacissima. Journal of Natural Products. 77(9). 2044–2053. 32 indexed citations
16.
Chai, Stella, Man Tong, Pak Shing Kwan, et al.. (2014). Regulatory role of miR-142-3p on the functional hepatic cancer stem cell marker CD133. Oncotarget. 5(14). 5725–5735. 62 indexed citations
17.
Chai, Stella & Stephanie Ma. (2013). Clinical implications of microRNAs in liver cancer stem cells. Chinese Journal of Cancer. 32(8). 419–426. 16 indexed citations
18.
Ma, Bin, Stella Chai, Na Li, et al.. (2012). Reversal of P-glycoprotein-mediated multidrug resistance by a synthetic α-aminoxy peptidomimetic. International Journal of Pharmaceutics. 424(1-2). 33–39. 23 indexed citations
19.
Wang, Jingrong, Hing‐Man Ho, Stella Chai, et al.. (2010). Quantitative Comparison of Ginsenosides and Polyacetylenes in Wild and Cultivated American Ginseng. Chemistry & Biodiversity. 7(4). 975–983. 28 indexed citations
20.
Chai, Stella, Kenneth K.W. To, & Ge Lin. (2010). Circumvention of multi-drug resistance of cancer cells by Chinese herbal medicines. Chinese Medicine. 5(1). 26–26. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026